TOBAM’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-150,200
Closed -$2.44M 455
2022
Q1
$2.44M Sell
150,200
-44,300
-23% -$1.14M 0.12% 112
2021
Q4
$9.22M Buy
194,500
+2,700
+1% +$162K 0.41% 70
2021
Q3
$13.9M Buy
191,800
+43,500
+29% +$3.15M 0.59% 59
2021
Q2
$12.4M Buy
+148,300
New +$9.78M 0.5% 64

Other funds holding NBP

TOBAM's NBP Position: Q2 2022 in Review

TOBAM sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 150,200 shares — an estimated $2.44M sold.

TOBAM first reported a position in NBP in Q2 2021 and held it in 4 quarters. The position peaked at $13.9M in Q3 2021. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • TOBAM reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • TOBAM sold 150,200 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $2.44M.
  • TOBAM first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 4 quarters.
  • TOBAM's NovaBridge Biosciences American Depositary Shares position peaked at $13.9M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on TOBAM's 13F filing for Q2 2022, filed 2 Aug 2022.